MSc Clinical Drug Development

The Clinical Drug Development MSc is a cutting-edge program offered by Queen Mary University of London. The course is suited for graduates in life sciences or health disciplines wishing to further their skills and knowledge in the area of clinical drug development. The program's curriculum provides an in-depth understanding of drug development pathways.Course Content: The course introduces students to all elements of drug development, particularly focusing on clinical trials, legislation, personalized medicine, data analysis, and the scientific basis for drug discovery and development.Key Modules: The MSc is centred around four compulsory modules, namely 'Basic Principles of Drug Discovery I & II', 'Clinical Development', 'Clinical Pharmacology', and 'Clinical Trials: Principles and Methods'. It also offers a range of optional modules including 'Advanced Immunology', 'Ethics in Medicine', 'Pharmaceutical Public Health', and 'Regulatory affairs: Pharmacokinetics and Medical Devices'.Future Careers: On completion of the course, graduates often go on to job roles in the pharmaceutical industry, Contract Research Organizations (CRO), Universities, NHS, as well as roles in Policy Development and Consultancy. Additionally, the course offers a robust foundation for a career or further research in areas related to drug discovery and development.For more information on this course, please visit the official course page: Clinical Drug Development MSc